Precies....en DIT staat op de site van Salix....
Waarom kiezen ze dan voor Ruconest? Setr in het firmament??
From our corporate office in Raleigh, North Carolina, we license, develop, and market products such as XIFAXAN® (rifaximin) 550 mg, RUCONEST® (C1 esterase inhibitor [recombinant]), RELISTOR® (methylnaltrexone bromide), APRISO® (mesalamine), GIAZO® (balsalazide disodium), MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution), OSMOPREP® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP), SOLESTA®, FULYZAQ® (crofelemer), DEFLUX®, UCERIS® (budesonide) extended release tablets, UCERIS® (budesonide) rectal foam, GLUMETZA® (metformin), CYCLOSET® (bromocriptine mesylate) and ZEGERID® (omeprazole/sodium bicarbonate) to US healthcare professionals.